| | Age, sex | Clinical presentation | Endocrine abnormality | Pathology | Therapy | OS (months) |
| | 28, M [16] | HA, CN II/V | — | B-cell | Chemo + Rd | 6, alive | | 49, M [12] | HA, CN VIII, Nys | Hypo, DI, PRL | B-cell | Ste | n.d. | | 48, M [4] | HA, CN VI, F, S&WL, nausea | — | B-cell | Antituberculous therapy | 0.3, dead | | 73, F [13] | HA, fatige, CN VI | Hypo, DI, PRL | B-cell | Ste + Rd | 21.6, alive | | 53, M [11] | HA, CN VI | — | T-cell | Rd | 18, alive | | 48, M [3] | HA, CN III/VI | — | B-cell | n.d. | n.d. | | 67, F [9] | CN II/III | Hypo | B-cell | Rd | 4M, alive | | 82, M [1] | HA, CN II | Hypo, DI | B-cell | Rd | n.d. | | 65, M [10] | n.d. | Hypo, PRL | B-cell | Chemo | 0.5, alive | | 44, M [15] | HA, CN II | — | B-cell | Chemo + MTx + Rd | n.d. | | 86, F [31] | F, S&WL | Hypo, DI | B-cell | Chemo | 3, dead | | 15, M [14] | F, S&WL | Hypo, DI | B-cell | Chemo + HD MTx | 17, alive | | 74, M [8] | CN II, F, S&WL, mental status change | Hypo, | B-cell | Rd | 1.5, dead | | 65, M [8] | CN VI, retrobulbar pain | Hypo, | B-cell | Chemo | 24, dead | | 64, F [7] | nausea, diarrhea, edema | Hypo, DI | B-cell | Chemo + Rd | 15, dead | | 47, M [5] | F, S&WL | Hypo, | T-cell | Chemo + i.t. MTx + Rd | 5, alive | | 26, M [6] | HA, CN VI, F, S&WL | Hypo, PRL | NK/T-cell | Chemo + i.t. MTx + Rd | 6, dead | | 49, F [2] | HA, F, S&WL | Hypo, DI, PRL | B-cell | MTx | 48, alive | | 26, F [17] | HA, F, S&WL | Hypo, PRL | B-cell | — | 0.5, dead |
|
|
